Levetiracetam for seizures after liver transplantation
- 22 March 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Neurology
- Vol. 64 (6) , 1084-1085
- https://doi.org/10.1212/01.wnl.0000154598.03596.40
Abstract
Seizures may occur after orthotopic liver transplantation. Antiepileptic drugs (AEDs) are used to treat these seizures, but the immunosuppressant regimen also may be altered. Levetiracetam is an attractive treatment because of its efficacy, lack of hepatic enzyme induction, and its rapid attainment of serum levels. Treatment with levetiracetam is efficacious, and levetiracetam-treated patients require significantly lower doses of immunosuppressant medications to achieve an equivalent antirejection effect.Keywords
This publication has 10 references indexed in Scilit:
- The New Antiepileptic DrugsJAMA, 2004
- Neurologic complications of liver transplantation in adultsNeurology, 2003
- Levetiracetam monotherapy for liver transplant patients with seizuresTransplantation Proceedings, 2003
- Levetiracetam: A Different Approach to the Pharmacotherapy of EpilepsyAnnals of Pharmacotherapy, 2002
- Clinical Pharmacokinetics of SirolimusClinical Pharmacokinetics, 2001
- CalendarNeurology, 2000
- Central nervous system complications in liver transplant recipients – incidence, timing, and long‐term follow‐upClinical Transplantation, 2000
- Pharmacokinetics of tacrolimus: clinically relevant aspectsTransplantation Proceedings, 1999
- Causes and outcome of seizures in liver transplant recipientsNeurology, 1996
- Clinical Pharmacokinetics of CyclosporinClinical Pharmacokinetics, 1986